MicroStrategy (MSTR) may be replacing biotech company Moderna (MRNA) in the NASDAQ 100 Index (NASDAQ-100), according to Bloomberg Terminal.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.